Skip to content
Forge Biologics
  • About
    • About
    • Mission & Approach
    • Leadership
    • Board
  • Services
    • Manufacturing Services
    • Technology
  • Science
    • Science
    • Pipeline
    • About Gene Therapy
    • FBX-101 for Krabbe Disease
  • Careers
  • News & Insights
    • News
    • Events
    • Insights
    • Media Kit
  • Connect

Gene Therapy

Forge Biologics to Present at Chardan’s 6th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
Forge Biologics to Participate in Upcoming Investor Conferences and Presentations in March 2022
Designing for the Future of Cell and Gene Therapy Facilities
44 Thriving Biotech Startups (2021)
Forge Biologics to Present at 2021 Cell & Gene Meeting on the Mesa
Current and Future Prospects for Gene Therapy for Rare Genetic Diseases Affecting the Brain and Spinal Cord
Solid Biosciences, Forge Biologics Enter Development and Manufacturing Pact
EMA Orphan Drug Designation for Forge Biologics’ gene therapy for Krabbe disease
Forge Biologics Announces Closing of $120 Million Series B Financing

Posts navigation

  • 1
  • 2
  • 3
  • »
Copyright Forge Biologics - All Rights Reserved Cookie Notice | Privacy Policy

I agree to the Cookie Notice and Privacy Policy

I agree